NEOG
$19.06
Neogen Cp
($.25)
(1.29%)
NEOG
Earnings Whisper ®
N/A
1st Quarter August 2023
Consensus:  $0.14
Revenue:  $234.10 Mil
Thursday
Oct 26
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, July 27, 2023

What do you expect when NEOG reports earnings?
Beat
Meet
Miss

Where is NEOG's stock price going from here?
Up
Flat
Down
Stock chart of NEOG
Analysts
Summary of analysts' recommendations for NEOG
Score
Grade
Pivots
Resistance
$19.75
$19.59
$19.32

$19.16

Support
$18.89
$18.73
$18.46
Tweet
Growth
Description
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Peers
Vertex PharmaceuticalsRegeneron PharmaceuticalsBioMarin PharmaceuticalArray TechnologiesBristol-Myers SquibbEli LillyJohnson & JohnsonMerck & Co.Ultragenyx PharmaceuticalPfizer